Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
F
Frontier Biotechnologies Inc
SSE:688221
Frontier Biotechnologies Inc
SSE:688221
Price:
16.87
CNY
2.74%
Market Closed
Market Cap:
¥6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Frontier Biotechnologies Inc
SSE:688221
|
CN |
|
S
|
Stellar Capital Services Ltd
BSE:536738
|
IN |
|
A
|
Arkema SA
DUS:V1S
|
FR |
|
S
|
Suprema HQ Inc
KOSDAQ:094840
|
KR |
|
H
|
Huntington Bancshares Inc
LSE:0J72
|
US |
|
G
|
General Dynamics Corp
XHAM:GDX
|
US |
|
Xlife Sciences AG
SIX:XLS
|
CH |
|
Sandvik AB
OTC:SDVKF
|
SE |
|
C
|
China Citic Bank Corp Ltd
HKEX:998
|
CN |
|
T
|
Triveni Enterprises Ltd
BSE:538569
|
IN |
|
Intel Corp
MIL:1INTC
|
US |
|
Tesla Inc
LSE:0R0X
|
US |
|
P
|
Phillips 66
SWB:R66
|
US |
|
Futura Medical PLC
LSE:FUM
|
UK |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Frontier Biotechnologies Inc's stock price target?
Not Available
Frontier Biotechnologies Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Frontier Biotechnologies Inc?
Projected CAGR
12%
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 81%. The projected CAGR for the next 3 years is 12%.